Furthermore, it is carefully suggested that if growth hormone is used at a low dose under strict metabolic control, it can increase muscle mass and insulin sensitivity while cutting down visceral fat and preventing the development of T2DM [40–42]. The gene discussed is INS; the disease is type 2 diabetes mellitus.